Published in Leuk Lymphoma on September 01, 2003
Ultrasound-guided central venous catheterization in cancer patients improves the success rate of cannulation and reduces mechanical complications: a prospective observational study of 1,978 consecutive catheterizations. World J Surg Oncol (2010) 1.30
Long-term use of peripherally inserted central venous catheters for cancer chemotherapy in children. Support Care Cancer (2005) 1.16
Safety and effectiveness of central venous catheterization in patients with cancer: prospective observational study. J Korean Med Sci (2010) 1.12
Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. J Thromb Haemost (2011) 1.05
Computer identification of symptomatic deep venous thrombosis associated with peripherally inserted venous catheters. AMIA Annu Symp Proc (2007) 0.82
Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC). Support Care Cancer (2015) 0.81
Retrospective cohort analysis comparing the incidence of deep vein thromboses between peripherally-inserted and long-term skin tunneled venous catheters in hemato-oncology patients. Thromb J (2015) 0.81
Increased risk of venous thromboembolism in patients with acute leukaemia. Br J Cancer (2006) 0.81
A case-control study to identify risk factors for totally implantable central venous port-related bloodstream infection. Cancer Res Treat (2014) 0.80
Peripherally inserted central catheter thrombosis incidence and risk factors in cancer patients: a double-center prospective investigation. Ther Clin Risk Manag (2015) 0.79
CT and MRI evaluation of cardiac complications in patients with hematologic diseases: a pictorial review. Int J Cardiovasc Imaging (2015) 0.78
The incidence and risk factors of peripherally inserted central catheter-related infection among cancer patients. Ther Clin Risk Manag (2015) 0.78
High risk of deep vein thrombosis associated with peripherally inserted central catheters in lymphoma. Oncotarget (2016) 0.75
Catheter thrombosis during primary percutaneous coronary intervention for acute ST elevation myocardial infarction despite subcutaneous low-molecular-weight heparin, acetylsalicylic acid, clopidogrel and abciximab pretreatment. Can J Cardiol (2006) 0.75
Nomogram predicted risk of peripherally inserted central catheter related thrombosis. Sci Rep (2017) 0.75
Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet (2001) 7.92
Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med (1993) 7.67
Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 4.76
Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst (1997) 4.23
Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study. Lancet (1998) 3.83
Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 3.25
Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. N Engl J Med (2001) 3.07
Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. Am J Med (1996) 2.51
The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Engl J Med (1995) 2.49
Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study. Lancet (1999) 2.48
Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet (1984) 2.47
Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 2.47
Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung. Am J Surg Pathol (2001) 2.42
Hemoconcentration: an early marker of severe and/or necrotizing pancreatitis? A critical appraisal. Am J Gastroenterol (2001) 2.28
Development and validation of a food frequency questionnaire in Spain. Int J Epidemiol (1993) 2.23
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
Tamoxifen for breast cancer among hysterectomised women. Lancet (2002) 2.11
Therapy for testicular cancer in Central and Eastern Europe. Lancet (1990) 2.08
Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results. J Thromb Haemost (2012) 2.04
[Prevalence and risk factors of hepatitis C virus infection in a hospitalized population in a gastroenterology unit. Role of endoscopic biopsies]. Gastroenterol Clin Biol (1995) 2.01
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation. J Thromb Haemost (2003) 1.95
Mother-to-child transmission of hepatitis C virus detected by nested polymerase chain reaction. J Infect Dis (1992) 1.90
Low-dose subcutaneous alemtuzumab in refractory chronic lymphocytic leukaemia (CLL): results of a prospective, single-arm multicentre study. Leukemia (2009) 1.80
Chronic pancreatitis: report from a multicenter Italian survey (PanCroInfAISP) on 893 patients. Dig Liver Dis (2008) 1.74
Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy. Ann Oncol (2005) 1.72
Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J Natl Cancer Inst (1997) 1.68
Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia. Genomics (1997) 1.68
Outcome of special types of luminal breast cancer. Ann Oncol (2011) 1.67
Trends of cancer mortality in Europe, 1955-1989: II, Respiratory tract, bone, connective and soft tissue sarcomas, and skin. Eur J Cancer (1992) 1.66
Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA (2001) 1.64
Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects. Ann Oncol (2005) 1.60
Skin signs in acute pancreatitis: frequency and implications for prognosis. J Intern Med (2009) 1.58
Changing mortality from esophageal cancer in males in Denmark and other European countries, in relation to changing levels of alcohol consumption. Cancer Causes Control (1990) 1.57
Carcinoma of the vulva. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 1.54
Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer. Ann Oncol (2010) 1.47
Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest (1992) 1.45
False-negative or false-positive: laboratory diagnosis of lupus anticoagulant at the time of commencement of anticoagulant: a rebuttal. J Thromb Haemost (2011) 1.45
Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer (2001) 1.44
Drop-outs in tamoxifen prevention trials. Lancet (1999) 1.44
Carcinoma of the corpus uteri. J Epidemiol Biostat (2001) 1.42
The accuracy of the International Normalized Ratio and the American College of Chest Physicians recommendations on the use of vitamin K to reverse over-anticoagulation. J Thromb Haemost (2012) 1.40
Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann Oncol (2011) 1.36
Carcinoma of the ovary. Int J Gynaecol Obstet (2003) 1.36
Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2012) 1.35
Epidemiology of mouth cancer in 1989: a review. J R Soc Med (1990) 1.34
Aspects of medical history and exocrine carcinoma of the pancreas: a population-based case-control study in The Netherlands. Int J Cancer (1992) 1.31
Carcinoma of the corpus uteri. Int J Gynaecol Obstet (2003) 1.30
Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2011) 1.29
Intake of foods and nutrients and cancer of the exocrine pancreas: a population-based case-control study in The Netherlands. Int J Cancer (1991) 1.29
Cancer control in women. Update 2003. Int J Gynaecol Obstet (2003) 1.29
Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation. Ann Intern Med (1998) 1.29
Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer (1991) 1.29
Mortality after the treatment of hyperthyroidism with radioactive iodine. N Engl J Med (1998) 1.28
Epidemiology of pancreas cancer (1988). Int J Pancreatol (1989) 1.27
Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT study: ISCOAT study group (Italian Study on Complications of Oral Anticoagulant Therapy). Thromb Haemost (1997) 1.27
Trends of cancer mortality in Europe, 1955-1989: I, Digestive sites. Eur J Cancer (1992) 1.26
Risk factors for cancer in hereditary pancreatitis. International Hereditary Pancreatitis Study Group. Med Clin North Am (2000) 1.26
Long-term oncological results of breast conservative treatment with oncoplastic surgery. Breast (2007) 1.24
Prognosis of chronic pancreatitis: an international multicenter study. International Pancreatitis Study Group. Am J Gastroenterol (1994) 1.24
Heterogeneous chromosomal aberrations generate 3' truncations of the NFKB2/lyt-10 gene in lymphoid malignancies. Blood (1994) 1.23
Venous thrombosis from air travel: the LONFLIT3 study--prevention with aspirin vs low-molecular-weight heparin (LMWH) in high-risk subjects: a randomized trial. Angiology (2002) 1.22
Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis. Eur J Cancer (2010) 1.21
Cigarette smoking and pancreas cancer: a case control study of the search programme of the IARC. Int J Cancer (1996) 1.21
Reported family aggregation of pancreatic cancer within a population-based case-control study in the Francophone community in Montreal, Canada. Int J Pancreatol (1992) 1.21
Nutritional factors and pancreatic cancer: a case-control study from south-west Poland. Int J Cancer (1991) 1.21
Nutritional factors and pancreatic cancer in the francophone community in Montréal, Canada. Int J Cancer (1991) 1.20
Carcinoma of the cervix uteri. J Epidemiol Biostat (2001) 1.19
Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse. Ann Oncol (2012) 1.19
Is the increased incidence of primary malignant brain tumors in the elderly real? J Natl Cancer Inst (1990) 1.17
Antenatal risk factors for malignant brain tumours in New South Wales children. Int J Cancer (1994) 1.16
Epidemiology of pancreatic diseases in Lüneburg County. A study in a defined german population. Pancreatology (2002) 1.16
Epidemiology of laryngeal cancer. Eur J Cancer B Oral Oncol (1996) 1.16
Genetic polymorphism of N-acetyltransferases, glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase in relation to malignant and benign pancreatic disease risk. The International Pancreatic Disease Study Group. Eur J Cancer Prev (1998) 1.15
Chronic pancreatitis and other risk factors for pancreatic cancer. Gastroenterol Clin North Am (1999) 1.14
Acute pancreatitis: does gender matter? Dig Dis Sci (2001) 1.12
Carcinoma of the cervix uteri. Int J Gynaecol Obstet (2003) 1.12
Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes. Breast Cancer Res Treat (2011) 1.12
Epidemiology of gallbladder cancer. Hepatogastroenterology (1999) 1.11
Minimal and small size invasive breast cancer with no axillary lymph node involvement: the need for tailored adjuvant therapies. Ann Oncol (2004) 1.10
Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2011) 1.10
Carcinoma of the ovary. J Epidemiol Biostat (2001) 1.09
In vitro correction of the abnormal multimeric structure of von Willebrand factor in type IIa von Willebrand's disease. Proc Natl Acad Sci U S A (1985) 1.08
Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about? Ann Oncol (2003) 1.08
Decrease in mortality from benign prostatic hyperplasia: a major unheralded health triumph. J Urol (1996) 1.07
Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer. Ann Oncol (2007) 1.06
Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative disease. Ann Oncol (2006) 1.06
Fatal outcome in acute pancreatitis: its occurrence and early prediction. Pancreatology (2001) 1.06
Effect of computer-aided management on the quality of treatment in anticoagulated patients: a prospective, randomized, multicenter trial of APROAT (Automated PRogram for Oral Anticoagulant Treatment). Haematologica (2001) 1.06
Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. J Thromb Haemost (2011) 1.05
Dietary fat, olive oil intake and breast cancer risk. Int J Cancer (1994) 1.05
Angiogenesis in myelodysplastic syndromes. Br J Cancer (1999) 1.05
Independent prognostic value of fascin immunoreactivity in stage III-IV colonic adenocarcinoma. Br J Cancer (2007) 1.04
Lung cancer and tobacco smoking. Lung Cancer (1995) 1.04
Cure of multiple myeloma -- more hype, less reality. Bone Marrow Transplant (2006) 1.03
High prevalence of Helicobacter pylori infection in patients with colonic adenomas and carcinomas. J Clin Gastroenterol (1997) 1.03
Perinatal and early postnatal risk factors for malignant brain tumours in New South Wales children. Int J Cancer (1994) 1.03
Nipple sparing mastectomy: can we predict the factors predisposing to necrosis? Eur J Surg Oncol (2011) 1.03
A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy. Thromb Haemost (2000) 1.03